Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Cristina P. Vicente, Li He, Mauro S.G. Pavão, Douglas M. Tollefsen

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Heparin cofactor II (HCII) is a plasma protein that inhibits thrombin rapidly in the presence of dermatan sulfate or heparin. We previously reported that the time to thrombotic occlusion of the carotid artery after photochemical injury was shorter in HCII-def icient mice than in wild-type control animals. In this paper, we describe the antithrombotic activity of dermatan sulfate in wild-type and HCII-deficient mice. Intravenous administration of porcine skin dermatan sulfate induced a dose-dependent prolongation of the carotid artery occlusion time in HCII+/+ mice that was not observed in HCII -/- animals. Pharmacokinetic studies suggested that porcine skin dermatan sulfate expresses antithrombotic activity after being transferred from the plasma to sites in the vessel wall. Using invertebrate dermatan sulfate preparations, we showed that N-acetylgalactosamine-4-O-sulfate residues are required for the HCII-dependent antithrombotic effect. Furthermore, the invertebrate dermatan sulfates, which have higher charge densities than mammalian dermatan sulfate, slightly prolonged the thrombotic occlusion time of HCII-/- mice. These results indicate that HCII mediates the antithrombotic effect of porcine skin dermatan sulfate after injury to the carotid arterial endothelium in mice, whereas more highly charged dermatan sulfates possess weak antithrombotic activity independent of HCII.

Original languageEnglish
Pages (from-to)3965-3970
Number of pages6
Issue number13
StatePublished - Dec 15 2004


Dive into the research topics of 'Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice'. Together they form a unique fingerprint.

Cite this